structure-based

Now, with our knowledge of the drug's molecular mechanism, all of a sudden we can use all the tools of modern drug discovery, which means structure-based, protein-targeted approaches, said Barry.

New Treatment Potential Found in Popular TB Drug 2011

Identification of structure-based antisickling peptides that inhibit Hb S polymerization

Sickle cell disease research at The Children's Hospital 2010

Now, with our knowledge of the drug's molecular mechanism, all of a sudden we can use all the tools of modern drug discovery, which means structure-based, protein-targeted approaches, said Barry.

New Treatment Potential Found in Popular TB Drug 2011

Ramakrishnan, Steitz and Yonath have all imaged the molecular interactions between ribosomes and antibiotics, providing key data to help guide structure-based drug design of new antibiotics.

The Nobel Prize in Chemistry 2009 - Speed Read 2009

Through a process called structure-based drug design, Olson's team finds new drug molecules with chemical components to stop AIDS/HIV from spreading throughout the body.

Tasha Mitchell: PC Users Can Help Discover New Drugs to Treat AIDS & Other Diseases 2009

Note that this Ph.D. “glut” is not the fault of immigration, but of more fundamental defects in the system (e.g., one tenured professor + 75 students and postdocs; sixty-five vice presidents + five structure-based drug designers).

Matthew Yglesias » Visas for Grads 2007

If the original poster is writing YA as opposed to pic books I urge him/her to get the screenwriting book, SAVE THE CAT, or another structure-based book on screenwriting.

But You're Still One of Us Editorial Anonymous 2008

If you don't because lying is wrong, or do because it's justified by a particular scripture or doctrinal rule, you probably are structure-based.

Philocrites: Do Unitarian Universalists have morals? 2004

The process helped reinforce managers' results-based influence rather than traditional structure-based zones of control.

Forbes.com: News Steve Denning 2011

ARIAD's approach to structure-based drug design has led to three internally discovered, molecularly targeted product candidates for drug-resistant and difficult-to-treat cancers, including certain forms of chronic myeloid leukemia, soft tissue and bone sarcomas and non-small cell lung cancer.

unknown title 2011